Sign in

CIK 0001287098

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAXCYTE, INC.

Sign in to watch
Ticker
MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522210438
Phone
+1 301-517-5556
Business address
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
Former names
MAXCYTE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale 10% owner sold 3,235,548 shares at $4.30 ($13,912,856)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy Director bought 20,000 shares at $11.12 ($222,400)
  11. 4 Open-market sale EVP and General Counsel sold 75,000 shares at an average $12.31 ($923,376)
  12. 4 Open-market sale Chief Financial Officer sold 150,000 shares at an average $12.31 ($1,846,567)
  13. 4 Open-market sale EVP, Global Sales sold 125,105 shares at an average $12.31 ($1,540,079)
  14. 4 Open-market sale SVP and CAO sold 150,000 shares at an average $12.29 ($1,843,647)
  15. 4 Open-market sale President and CEO sold 300,000 shares at an average $12.31 ($3,692,932)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 9 · 163 filings